{
  "meta": {
    "title": "Pediatric_Musculoskeletal_Disorders",
    "url": "https://brainandscalpel.vercel.app/pediatric-musculoskeletal-disorders-8ffbca62.html",
    "scrapedAt": "2025-11-30T14:12:22.298Z"
  },
  "questions": [
    {
      "text": "A group of researchers is currently studying the process of bone remodeling. Two primary cells, osteoblasts and osteoclasts, play an essential role in the remodeling process. Which of the following is true regarding these cells? &#160;",
      "choices": [
        {
          "id": 1,
          "text": "Osteoblasts induce the differentiation of osteoclasts from precursor cells via secretion of RANK ligand. &#160;&#160;"
        },
        {
          "id": 2,
          "text": "Osteoclasts resorb bone by creating an alkaline environment via alkaline phosphatase &#160;"
        },
        {
          "id": 3,
          "text": "Osteoblasts activate osteoclasts via secretion of osteoprotegerin &#160;"
        },
        {
          "id": 4,
          "text": "Osteoblasts and osteoclasts originate from mesenchymal stem cells of the periosteum &#160;"
        },
        {
          "id": 5,
          "text": "Osteoclasts activate osteoblasts via secretion of RANK-L &#160;"
        }
      ],
      "correct_choice_id": 1,
      "solution": "Bone remodeling is a complex process that involves a constant interplay of the breakdown of old bone and the formation of newer bone. The two major cell types involved in this process are <strong>osteoblasts </strong>and <strong>osteoclasts</strong>. &#160; <br><br>Osteoclasts are phagocytosing cells that originate from<strong> the fusion of monocytes</strong>. RANK-ligand produced by osteoblasts induces the differentiation and activation of <strong>osteoclasts</strong> by binding &#160;RANK receptors. Once activated, osteoclasts secrete collagenase, breaking down bony collagen and hydrochloric acid, dissolving hydroxyapatite into circulation. &#160; Osteoblasts are bone-forming cells that originate from mesenchymal stem cells of the periosteum. They secrete RANK-ligand, which activates osteoclasts by binding RANK receptors. Osteoblasts also produce <strong>osteoprotegerin</strong>, which binds RANK-L and prevents RANK-RANKL interactions, thus limiting osteoclast activation. In addition, osteoblasts secrete collagen to catalyze the mineralization of bones by trapping calcium ions and phosphate into hydroxyapatite. This mineralization process is mediated mainly by the enzyme alkaline phosphatase, which creates an alkaline environment. &#160;<br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ Osteoblasts induce the differentiation of osteoclasts from precursor cells via secretion of RANK ligand. &#160;&#160;:</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Osteoclasts resorb bone by creating an alkaline environment via alkaline phosphatase &#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Osteoblasts contribute to bone formation by trapping calcium and phosphate in the bone (hydroxyapatite) using alkaline phosphatase. On the other hand, osteoclasts resorb bone and free hydroxyapatite and create an acidic environment. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Osteoblasts activate osteoclasts via secretion of osteoprotegerin &#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Osteoblasts secrete RANK ligand (RANK-L), which binds the RANK receptors on osteoclasts and activates them. Osteoblasts secrete osteoprotegerin, which inhibits the binding of RANKL-RANK. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Osteoblasts and osteoclasts originate from mesenchymal stem cells of the periosteum &#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Osteoblasts originate from mesenchymal stem cells of the periosteum, while osteoclasts differentiate from monocytes. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Osteoclasts activate osteoblasts via secretion of RANK-L &#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Osteoblasts activate osteoclasts via secretion of RANK-L. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A researcher uses an electron microscope to visualize muscle fibers and captures the image below. Which of the following zones of the sarcomere will shorten during muscle contraction? &#160;<br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/zze26XuaTrqIIWICFz-FJ02PQK_V1Vdl/_.png\"></div><br>",
      "choices": [
        {
          "id": 1,
          "text": "Zone 1 only"
        },
        {
          "id": 2,
          "text": "Zone 2 only"
        },
        {
          "id": 3,
          "text": "Zone 3 only"
        },
        {
          "id": 4,
          "text": "Zone 4 only"
        },
        {
          "id": 5,
          "text": "Zone 5 only"
        },
        {
          "id": 6,
          "text": "Zones 4 and 5&#160;"
        },
        {
          "id": 7,
          "text": "Zones 1, 4, and 5&#160;"
        }
      ],
      "correct_choice_id": 7,
      "solution": "The <strong>sarcomere&#160;</strong>is the smallest functional unit of striated muscle. Shortening of some areas of the sarcomere helps facilitate muscle contraction. The different structures and zones that compose a sarcomere are shown in the image above. &#160; <br><br>During muscle contraction, the section of the sarcomere that <strong>contains only actin</strong> (termed I band) and the section that <strong>contains only myosin</strong> (termed H band) shorten in length. In addition, the <strong>overall length</strong> of the sarcomere shortens. &#160;<br><br>In contrast, the <strong>length of the myosin fibers&#160;</strong>(termed A band) remains unchanged during muscle contraction. Furthermore, the thickness of the <strong>Z-lines</strong>, which mark the boundaries of each sarcomere, and <strong>M-line</strong>, which serve as the attachment site for myosin, remain unchanged during contraction.<br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/jN6g4Zo2TQuXC7va3cMrm1xDTziY8ACK/_.png\"></div><br><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Zone 1 only:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>Zone 1 refers to the distance from one Z-line to another. While this distance is reduced as the muscle contracts, so is the section of the sarcomere that contains only actin (Zone 4) and the section that contains only myosin (Zone 5). &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Zone 2 only:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Zone 2 refers to the length of the myosin filaments. The myosin filaments are of fixed length and do not shorten during muscle contraction. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Zone 3 only:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>Zone 3 refers to the width of the Z-line, which forms the border of each sarcomere. The width of the Z-line remains unchanged during muscle contraction. &#160;&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Zone 4 only:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>Zone 4 is the section of the sarcomere that contains only actin. While this distance is reduced as the muscle contracts, so is the overall length of the sarcomere (Zone 1) and the length of the section that contains only myosin (Zone 5). &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Zone 5 only:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Zone 5 is the section of the sarcomere that contains only myosin. While this distance is reduced as the muscle contracts, so is the overall length of the sarcomere (Zone 1) and the length of the section that contains only actin (Zone 4). &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Zones 4 and 5&#160;:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>The three zones that shorten during muscle contraction are Zone 1 (overall length of the sarcomere), Zone 4 (section of the sarcomere that contains only myosin), and Zone 5 (section of the sarcomere that contains only actin). &#160;</span></div><div style='margin-bottom: 12px;'><strong>✅ Zones 1, 4, and 5&#160;:</strong><br><span style='opacity:0.9'><strong>Correct: </strong>See Main Explanation.</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A researcher is studying skeletal muscle physiology. Baseline characteristics of a muscle sample obtained from a mouse are recorded. Which combination of changes to the number of muscle fibers recruited, frequency of muscle stimulation and velocity of muscle contraction will enable this muscle sample to generate the greatest force? &#160;",
      "choices": [
        {
          "id": 1,
          "text": ""
        },
        {
          "id": 2,
          "text": ""
        },
        {
          "id": 3,
          "text": ""
        },
        {
          "id": 4,
          "text": ""
        },
        {
          "id": 5,
          "text": ""
        }
      ],
      "correct_choice_id": 2,
      "solution": "There are five main factors that determine the force produced during a muscle contraction. These factors are described in the following table:<br>&#160; <div><img src=\"https://d16qt3wv6xm098.cloudfront.net/WMZtwL4YShGZop_N47QeigYvQ2idhOkG/_.png\"></div><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ :</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Increasing the frequency of muscle stimulation and number of muscle fibers recruited will increase the force of contraction. Increasing the velocity of contraction decreases the number of actin-myosin cross-bridges that can form, thereby decreasing the force of contraction. &#160;&#160;</span></div><div style='margin-bottom: 12px;'><strong>✅ :</strong><br><span style='opacity:0.9'><strong>Correct</strong>: See Main Explanation. &#160;&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ :</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Increasing the number of muscle fibers recruited and decreasing the velocity of contraction will increase the force of contraction. Decreasing the stimulation frequency will reduce the number of calcium ions released into the sarcoplasm, thereby decreasing the force of contraction. &#160;&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ :</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Decreasing the number of muscle fibers recruited will decrease the force of muscle contraction. &#160;&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ :</strong><br><span style='opacity:0.9'><strong>Incorrect</strong>: Decreasing the velocity of contraction will increase the force exerted during muscle contraction. Decreasing the number of fibers recruited and the frequency of stimulation will decrease the force of contraction. As a result, this combination of changes will not help the muscle sample produce the greatest force. &#160;&#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A researcher is studying skeletal muscle physiology. She identifies a protein that hydrolyzes adenosine triphosphate and uses the released energy to return the protein&#8217;s head to a cocked position. Which of the following structures does this protein most likely interact with during muscle contraction? &#160;",
      "choices": [
        {
          "id": 1,
          "text": "Tropomyosin"
        },
        {
          "id": 2,
          "text": "Sarcoplasmic reticulum"
        },
        {
          "id": 3,
          "text": "Actin"
        },
        {
          "id": 4,
          "text": "Transverse tubules"
        },
        {
          "id": 5,
          "text": "Dihydropyridine receptor"
        }
      ],
      "correct_choice_id": 3,
      "solution": "The protein this researcher identified is <strong>myosin</strong>. During muscle contraction, myosin binds with actin to cause muscle shortening. &#160; <br><br>Muscle contraction begins when an action potential reaches the neuromuscular endplate and triggers muscle cell depolarization. The depolarization wave propagates along <strong>transverse tubules</strong> to reach<strong>&#160;dihydropyridine receptors</strong>, which, when activated, cause <strong>ryanodine receptors</strong> to open and release calcium into the cytoplasm. Calcium binds to <strong>troponin&#160;</strong>and leads to a conformational change, moving <strong>tropomyosin&#160;</strong>away from the myosin-binding sites on actin. &#160; <br><br>Before <strong>myosin&#160;</strong>can bind to actin, it first needs to power up. Part of the myosin head is an ATPase, an enzyme that cleaves ATP into ADP and a phosphate ion to release energy. The energy cocks the myosin head back into its <strong>high-energy position</strong>. The myosin head then binds to the actin filament at designated sites, resulting in <strong>cross-bridge formation</strong>. The myosin head pulls on the actin filament in a movement called the <strong>power stroke</strong>, which leads to muscle shortening. &#160; &#160;<br><br>Once the power stroke completes, the ADP and phosphate ion detach from the myosin head. A new ATP molecule binds, causing the myosin head to detach from actin. The new ATP is cleaved, and the energy is used to re-cock the myosin head into a high-energy position for the next power stroke. &#160; <br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/yPWgt3XwTfS6KGjatZQA7mDlQUu152s1/_.png\"></div><br><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Tropomyosin:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>Myosin contains an ATPase that breaks down adenosine triphosphate (ATP) to release energy. The energy causes the myosin head to return to a high-energy cocked position. During muscle contraction, myosin binds to and pulls on actin filaments leading to muscle shortening. &#160;&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Sarcoplasmic reticulum:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>The protein this researcher identified is most likely myosin. While the release of calcium from the sarcoplasmic reticulum is necessary for muscle contraction, myosin does not interact directly with this structure. &#160;</span></div><div style='margin-bottom: 12px;'><strong>✅ Actin:</strong><br><span style='opacity:0.9'><strong>Correct:&#160;</strong>See Main Explanation. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Transverse tubules:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>The transverse tubules are infoldings of the cellular membrane that penetrate the center of skeletal and cardiac muscle. They are responsible for synchronizing action potential conduction and muscle contraction. Transverse tubules do not interact directly with myosin, the protein identified by this researcher.&#160;&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Dihydropyridine receptor:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>Dihydropyridine receptor activation causes ryanodine receptors, a type of calcium channel found on the sarcoplasmic receptor, to open. In turn, calcium is released into the cytoplasm and promotes muscle contraction. However, dihydropyridine receptors do not interact directly with myosin, the protein identified by this researcher. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A biologist is studying smooth muscle physiology and identifies a protein that phosphorylates the light chain of myosin and increases myosin ATPase activity. Which of the following is most directly involved in regulating the activity of this protein? &#160;",
      "choices": [
        {
          "id": 1,
          "text": "Calmodulin"
        },
        {
          "id": 2,
          "text": "Transverse tubules"
        },
        {
          "id": 3,
          "text": "Myosin-light chain phosphatase"
        },
        {
          "id": 4,
          "text": "Tropomyosin"
        },
        {
          "id": 5,
          "text": "Actin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "The protein this biologist identified is most likely <strong>myosin light-chain kinase</strong>, and its activity is regulated by calmodulin. &#160; &#160;<br><br>Smooth muscle contraction occurs when a stimulus causes <strong>L-type voltage-gated calcium channels</strong> to open. The influx of extracellular calcium triggers the release of more calcium from the sarcoplasmic reticulum in a phenomenon termed <strong>calcium-induced calcium release</strong>. The calcium binds to the protein <strong>calmodulin</strong>, which activates <strong>myosin light-chain kinase&#160;</strong>(MLCK). MLCK phosphorylates the myosin light chain and increases myosin ATPase activity, leading to <strong>cross-bridge formation</strong> and muscle contraction. &#160; <br><br>On the other hand, smooth muscle relaxation occurs when a combination of external signals (e.g. binding of acetylcholine or bradykinin receptors) and increased intracellular calcium induces <strong>nitric oxide synthase</strong> activity in endothelial cells surrounding the smooth muscle. This enzyme produces nitric oxide, which diffuses into the nearby muscle cells to <strong>increase cGMP production</strong> and <strong>activate myosin</strong> <strong>light-chain phosphatase</strong> (MLCP). MLCP then dephosphorylates myosin, thereby preventing myosin from binding with actin and terminating smooth muscle contraction. &#160;<br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>✅ Calmodulin:</strong><br><span style='opacity:0.9'><strong>Correct: </strong>See Main Explanation. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Transverse tubules:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>The transverse tubules are infoldings of the cellular membrane that penetrate the center of skeletal and cardiac muscles. They are responsible for helping synchronize action potential conduction and muscle contraction. In contrast, this researcher is studying a smooth muscle sample. &#160;&#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Myosin-light chain phosphatase:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>Myosin-light chain phosphatase is an enzyme found within smooth muscle cells. It is responsible for the dephosphorylation of myosin light chains and subsequent smooth muscle relaxation. However, myosin-light chain phosphatase is not responsible for regulating the activity of myosin light-chain kinase, which is the protein identified by this researcher. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Tropomyosin:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>Tropomyosin covers the myosin-binding sites on actin filaments in skeletal and cardiac muscle. In contrast, tropomyosin is not typically involved in smooth muscle contraction or relaxation. Tropomyosin needs to be removed before actin and myosin can bind and cause muscle contraction. &#160;</span></div><div style='margin-bottom: 12px;'><strong>❌ Actin:</strong><br><span style='opacity:0.9'><strong>Incorrect: </strong>This biologist most likely identified the protein myosin light-chain kinase. Actin is not directly involved in regulating the activity of this protein. &#160;</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 20-year-old woman is evaluated in the emergency department for a suspected generalized tonic-clonic seizure. The episode occurred an hour ago when she was with her roommate, who states the patient started uncontrollably flexing and extending her upper and lower limbs for 1 minute. She has a history of recurrent seizures for the past 2 years, and she lost partial vision due to occipital lobe infarction last year. Family history is not available because the patient was adopted as a child. Neurological examination shows decreased sensation and weakness of bilateral lower extremities. The patient is admitted for further evaluation. Serum lactate levels are 3.3 mmol/L. Skeletal muscle biopsy shows proliferation of mitochondria that appear bright red compared to the blue myofibers when stained with Gomori trichrome stain. This patient&#8217;s condition is best described as which of the following?",
      "choices": [
        {
          "id": 1,
          "text": "Myotonic dystrophy"
        },
        {
          "id": 2,
          "text": "Inflammatory myopathy"
        },
        {
          "id": 3,
          "text": "Myasthenia gravis"
        },
        {
          "id": 4,
          "text": "Oxidative phosphorylation disease"
        },
        {
          "id": 5,
          "text": "Ion channel myopathy"
        }
      ],
      "correct_choice_id": 4,
      "solution": "This patient&#8217;s <strong>neuromuscular lesions</strong>,<strong>&#160;ragged muscle fibers</strong> on biopsy, and <strong>elevated lactate levels&#160;</strong>are consistent with <strong>mitochondrial encephalomyopathy</strong>, most likely <strong>MELAS syndrome</strong> (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes).<br><br>MELAS is a rare genetic disorder that occurs when there are<strong>&#160;mutated mitochondria</strong> in muscle cells, especially skeletal muscle cells. The diseased mitochondria proliferate in an attempt to compensate for poor energy production and appear <strong>bright red&#160;</strong>compared to the blue myofibers, and they are therefore called \"<strong>ragged red fibers</strong>\" when stained with Gomori trichrome stain.<br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/W0FoFVn9QjydvXQ-OhS1GpeIQ0C4t0IM/_.jpg\"></div><br>Reproduced from Wikimedia Commons<br><br>Mitochondria are cellular organelles that are responsible for ATP production via oxidative phosphorylation. Therefore, mitochondrial defects tend to cause lactic acidosis and tend to affect tissues with highest metabolic rates (e.g., neural and muscular tissue). Although some mitochondrial proteins are encoded in the nuclear genome, mitochondria have their own mitochondrial DNA (mtDNA) as well. Mutations of mtDNA result in<strong>&#160;failure of oxidative phosphorylation</strong> and are the underlying cause of mitochondrial myopathies.<br><br>Besides MELAS, other mitochondrial myopathies include <strong>Leber hereditary optic neuropathy</strong>, which results in cell death in the optic nerve neurons, leading to subacute bilateral vision loss in teens/young adults, which is usually permanent.<br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Myotonic dystrophy:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Myotonic dystrophy is a multisystem disorder most commonly caused by the expansion of CTG trinucleotide repeat, affecting the DMPK gene. It is characterized by skeletal muscle weakness and myotonia, cardiac conduction abnormalities, and cataracts. Stroke-like symptoms, lactic acidosis, seizures, and ragged red fibers on skeletal muscle biopsy are not usually seen.</span></div><div style='margin-bottom: 12px;'><strong>❌ Inflammatory myopathy:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Inflammatory myopathies (e.g. polymyositis) results from lymphocytic inflammation of the skeletal muscle cells. Affected patients present with prominent proximal muscles weakness. Stroke-like symptoms, lactic acidosis, and seizures are not usually seen. &#8220;Ragged red fibers,&#8221; as indicated by the bright red mitochondria on biopsy, are also inconsistent with the diagnosis.</span></div><div style='margin-bottom: 12px;'><strong>❌ Myasthenia gravis:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Myasthenia gravis is caused by antibodies against the acetylcholine receptors on the postsynaptic membrane. Affected individuals most commonly present with fluctuating weakness and fatigability of ocular muscles. Stroke-like symptoms, lactic acidosis, and seizures are not usually seen.</span></div><div style='margin-bottom: 12px;'><strong>✅ Oxidative phosphorylation disease:</strong><br><span style='opacity:0.9'><strong>Correct:&#160;</strong>See Main Explanation.</span></div><div style='margin-bottom: 12px;'><strong>❌ Ion channel myopathy:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Ion channel myopathy manifests with episodes of myotonia and hypotonic paralysis, often after exercise. Intracytoplasmic, PAS-positive vacuoles can be seen on muscle biopsy.</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 4-year-old boy is brought to the office by his parents for evaluation of leg pain. He has been experiencing progressive leg pain over the past 3 months that is worse with activity. The parents report that the patient also has difficulty running and walking up stairs for the past year, and they have noticed that he always &#8220;walks on his toes.&#8221; He was adopted as an infant, and family history is unknown. Vitals are within normal limits. Height, weight and head circumference is at 20th percentile, similar to previous visits. Physical examination shows bilateral calf hypertrophy and thin, atrophied thighs. Extremities are nontender to palpation. When asked to rise from the floor the boy uses hand support to push himself to an upright position. He has a waddling gait. Which of the following laboratory tests will most likely help to develop a diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Karyotype analysis"
        },
        {
          "id": 2,
          "text": "Serum creatinine kinase level"
        },
        {
          "id": 3,
          "text": "Serum TSH level"
        },
        {
          "id": 4,
          "text": "Skeletal survey"
        },
        {
          "id": 5,
          "text": "Abdominal ultrasound"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<strong>Duchenne muscular dystrophy</strong> (DMD) is an <strong>X-linked recessive disorder</strong> that typically results from <strong>frameshift deletions or nonsense mutations</strong> in dystrophin genes leading to a <strong>truncated or absent dystrophin protein</strong>. It should be suspected in this patient with proximal muscle weakness and Gower sign (using hand support to push himself to an upright position). Enlargement of the calf is due to muscle replacement with fat (pseudohypertrophy), which is often associated with leg pain. In addition, a waddling gait and toe walking are common findings.<br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/7hFb5QD7TGud1hPuzKNCbR1aR62vtwqT/_.png\"></div><br><br>Later symptoms include <strong>wheelchair dependence&#160;</strong>by the age of 12, <strong>respiratory failure</strong> because of a weak diaphragm, scoliosis, and <strong>dilated cardiomyopathy</strong> and arrhythmias, since the dystrophin protein is also expressed in heart muscle.<br><br><strong>Serum creatinine kinase</strong> is markedly <strong>elevated</strong> in children with DMD and is at its peak around the age of 2 years. The levels typically fall thereafter, mainly due to the replacement of muscle by fat and fibrosis. <strong>Serum aldolase levels</strong>, aspartate transaminase (AST) and alanine transaminase (ALT) are also elevated. An elevated creatine kinase is followed by <strong>genetic testing</strong> to confirm the <strong>deletion of the dystrophin gene.</strong><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Karyotype analysis:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Karyotype analysis can help detect Down syndrome, which can cause motor delay. Affected patients have typical dysmorphic features (e.g., epicanthal folds, single palmar crease) and language delay. Gower sign and pseudohypertrophy of calves would be atypical.</span></div><div style='margin-bottom: 12px;'><strong>✅ Serum creatinine kinase level:</strong><br><span style='opacity:0.9'><strong>Correct:</strong> See Main Explanation.</span></div><div style='margin-bottom: 12px;'><strong>❌ Serum TSH level:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Serum TSH can be used as a screening test for hypothyroidism in this patient. Hypothyroidism in children can present with developmental delay and weakness, as well as decreased height velocity. This patient&#8217;s height is tracking consistently at the 20th percentile, and his other signs (e.g., calf hypertrophy, Gower sign) suggest a different diagnosis.</span></div><div style='margin-bottom: 12px;'><strong>❌ Skeletal survey:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Skeletal survey can be used in children to evaluate for suspected fractures or child abuse. Although patients with DMD are susceptible to fractures, this patient&#8217;s examination is nonfocal, and there is no evidence of child abuse.</span></div><div style='margin-bottom: 12px;'><strong>❌ Abdominal ultrasound:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Abdominal ultrasound can be obtained to evaluate WAGR syndrome to detect Wilms tumor. Affected patients present with aniridia, genitourinary abnormalities and intellectual disability. These findings are not present in this patient.</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 3-year-old boy is brought to the office by his parents for the evaluation of frequent falls. The parents report that the patient has had difficulty running and walking up stairs for the past year, and now they have noticed numerous unprovoked falls. Family history is unremarkable. Vitals are within normal limits. Physical examination shows enlarged and nontender calves bilaterally. When asked to rise from the floor, the boy uses hand support to push himself to an upright position. Serum creatinine kinase is 14,000 U/L. Molecular genetic testing reveals a large defective muscle protein due to the loss of 508 amino acid residues. Based on the suspected diagnosis, which of the following mutations is most likely involved in the pathogenesis of this patient&#8217;s condition?",
      "choices": [
        {
          "id": 1,
          "text": "Missense mutation"
        },
        {
          "id": 2,
          "text": "Repeat expansion mutation"
        },
        {
          "id": 3,
          "text": "Conservative mutation"
        },
        {
          "id": 4,
          "text": "Silent mutation"
        },
        {
          "id": 5,
          "text": "Frameshift mutation"
        }
      ],
      "correct_choice_id": 5,
      "solution": "This young boy with progressive<strong>&#160;proximal muscle weakness, Gower sign&#160;</strong>(using hand support to push himself to an upright position) and <strong>elevated creatinine kinase</strong> is most likely suffering from <strong>Duchenne muscular dystrophy (DMD)</strong>, an <strong>X-linked recessive</strong> disorder caused by <strong>frameshift deletion mutation</strong> in the dystrophin gene leading to the production of truncated or absent<strong>&#160;dystrophin protein</strong>. Besides frameshift mutation,<strong>&#160;nonsense mutations</strong> are also common in patients with DMD.<br><br>The dystrophin gene is a massive gene located on the X-chromosome that has 79 exons and is over 2 million base pairs in length, increasing the chances of <strong>spontaneous mutations.</strong> The normal function of this protein is to link intracellular actin with the dystrophin-associated protein complex, which links the actin cytoskeleton and the extracellular matrix to stabilize the sarcolemma. In the absence of dystrophin, cellular proteins like creatine kinase escape the damaged cell, and calcium enters the cell, ultimately leading to myonecrosis.<br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/EOQdgzbjSh2RhqM3gRaMXCkfSPSGK5Z0/_.png\"></div><br><br>Affected patients usually present at the <strong>age or 2-3 years</strong> with <strong>progressive muscle weakness</strong> that affects the <strong>proximal muscles</strong> before the distal and involves the<strong>&#160;lower extremities</strong> before the upper extremities. The patient often exhibits an abnormal <strong>waddling gait</strong> and<strong>&#160;pseudohypertrophy of the calf muscles</strong> (fibrofatty replacement of muscles). <strong>Gower sign</strong> is classic for DMD.<br><br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/qTXdlSQnR6Cz8XkZ3RSRWBu0QlWkngK3/_.png\"></div><br><br>Later symptoms include <strong>wheelchair dependence</strong> by the age of 12, <strong>respiratory failure&#160;</strong>because of a weak diaphragm, scoliosis, and <strong>dilated cardiomyopathy</strong> and arrhythmias, since the dystrophin protein is also expressed in heart muscle. Respiratory failure was previously the most common cause of death, but because of improvements in respiratory and spinal care, heart failure has superseded it as the most common cause of death. Complications often lead to a shortened lifespan. &#160;<br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Missense mutation:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Missense mutation refers to the base substitution code of one amino acid for a different amino acid one. Examples include sickle cell disease (substitution of glutamic acid with valine). The function of the resultant protein may be altered, but the size remains unchanged, unlike this patient&#8217;s genetic results.</span></div><div style='margin-bottom: 12px;'><strong>❌ Repeat expansion mutation:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Repeat expansion mutations can be seen in trinucleotide repeat disorders; an expansion of a nucleotide triple ultimately results in improper functioning of the protein. Examples include Huntington disease, fragile X disease, and myotonic dystrophy.</span></div><div style='margin-bottom: 12px;'><strong>❌ Conservative mutation:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Conservative mutation refers to the base substitution code of one amino acid for a different amino acid with a similar chemical structure. The function and size of the protein remains unchanged.</span></div><div style='margin-bottom: 12px;'><strong>❌ Silent mutation:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Silent mutation refers to the base substitution code for the same amino acid so that the same protein is produced. Silent mutation does not alter the protein function.</span></div><div style='margin-bottom: 12px;'><strong>✅ Frameshift mutation:</strong><br><span style='opacity:0.9'><strong>Correct:&#160;</strong>See Main Explanation.</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A study is carried out to evaluate X-linked recessive disorders in female carriers. The clinical features of eight female gene carriers of Duchenne muscular dystrophy were noted, and a relationship was established between the genotype and phenotype. Five of the eight cases were symptomatic and showed mild muscle weakness, difficulty walking, mild to moderate elevations of the serum creatinine kinase level, or myopathic changes on an electromyogram. Upon immunofluorescence, a mosaic pattern of dystrophin deficiency was found. Only two carriers were clinically asymptomatic. Which of the following genetic terms best describes the underlying cause for the difference in these patients&#8217; symptoms?",
      "choices": [
        {
          "id": 1,
          "text": "Anticipation"
        },
        {
          "id": 2,
          "text": "Codominance"
        },
        {
          "id": 3,
          "text": "Uniparental disomy"
        },
        {
          "id": 4,
          "text": "Lyonization"
        },
        {
          "id": 5,
          "text": "Loss of heterozygosity"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<strong>Duchenne muscular dystrophy</strong> (DMD) is an <strong>X-linked recessive disorder</strong> that results from frameshift deletion of dystrophin gene and usually manifests clinically in males. In females, however, only one X chromosome gets expressed, and the other X chromosome forms a transcriptionally inactive <strong>Barr body</strong>. This process is called<strong>&#160;X-inactivation</strong> or <strong>lyonization</strong>. If the inactivation is random, about half of the female&#8217;s cells have a functional dystrophin gene and the other half have a defective dystrophin gene. Such females are typically asymptomatic.<br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/vHduCfgMRZKcEF9I4wQZUsElSmWV2oPz/_.png\"></div>&#160;<br><br>If more cells end up with the defective dystrophin gene, and less with the functional one, then the females can end up being &#8220;manifesting carriers,&#8221; meaning that they manifest or show some symptoms. This process is called <strong>skewed inactivation</strong> of the X chromosome.<br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/43qzimCYTtOzkHRPLTtrVAphR6OYlU0n/_.png\"></div><br><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Anticipation:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Anticipation refers to an increased severity or earlier onset of disease in succeeding generations and is most commonly observed in diseases caused by trinucleotide repeat expansion (e.g., Huntington disease, fragile X syndrome).</span></div><div style='margin-bottom: 12px;'><strong>❌ Codominance:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>When both alleles contribute to the phenotype of the heterozygote, it is referred to as codominance. This phenomenon is not responsible for the variable presentation in females with Duchenne muscular dystrophy.</span></div><div style='margin-bottom: 12px;'><strong>❌ Uniparental disomy:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> When the offspring receives 2 copies of a chromosome from 1 parent and no copies from the other parent, it is called uniparental disomy. Most cases are phenotypically normal, except for the cases when the parent is the carrier of autosomal recessive disorder. Examples include Prader-Willi syndrome and Angelman syndrome.</span></div><div style='margin-bottom: 12px;'><strong>✅ Lyonization:</strong><br><span style='opacity:0.9'><strong>Correct:&#160;</strong>See Main Explanation.</span></div><div style='margin-bottom: 12px;'><strong>❌ Loss of heterozygosity:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Loss of heterozygosity refers to the phenomenon where, if a patient inherits or develops a mutation in a tumor suppressor gene, the complementary allele must be deleted or mutated before cancer develops. This phenomenon is not responsible for the difference in Duchenne muscular dystrophy manifestation in females.</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 14-year-old boy is brought to the office by his father because of progressive muscle weakness and stiffness for the past several months. The patient has had frequent episodes of hand stiffness where he states he &#8220;couldn&#8217;t let go of objects.&#8221; He also has increased difficulty with facial expression, especially with smiling and frowning. The patient reports occasional difficulty with speech and a heavy feeling in the tongue. Past medical history is noncontributory. He was adopted as an infant, and the biological family history is unknown. Vitals are within normal limits. Physical examination shows ptosis, temporal wasting and thin cheeks. Hand muscles are weak bilaterally, and the patient has difficulty opening his hand after squeezing the physician&#8217;s fingers. Babinski sign is absent bilaterally, and deep tendon reflexes are normal throughout. Testicular volume is small for age. Which of the following is the most likely cause of this patient&#8217;s condition?",
      "choices": [
        {
          "id": 1,
          "text": "Autoantibodies against the acetylcholine receptors"
        },
        {
          "id": 2,
          "text": "Lymphocytic inflammation of the skeletal muscle cells"
        },
        {
          "id": 3,
          "text": "Cytosine-thymine-guanine trinucleotide repeat expansion"
        },
        {
          "id": 4,
          "text": "Imprinting of UBE3A on maternal copy of chromosome 15"
        },
        {
          "id": 5,
          "text": "Frameshift deletion mutation in the dystrophin gene"
        }
      ],
      "correct_choice_id": 3,
      "solution": "This boy with <strong>hand stiffness and muscle atrophy</strong> associated with ptosis and <strong>difficulty with speech and facial expressions</strong> has findings suggestive of<strong>&#160;myotonic dystrophy</strong> (MD).<br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/-SQYIoQxTqyU5Q7OmmJAu2vZTb_2rqyb/_.png\"></div><br><br>MD is a multisystem,<strong>&#160;autosomal dominant</strong> disorder most commonly caused by the <strong>expansion of cytosine-thymine-guanine (CTG)</strong> trinucleotide repeat, affecting the <strong>dystrophia myotonica protein kinase (DMPK)</strong> gene, located on the long arm of chromosome 19. Although the severity and onset of MD correlates loosely with the cytosine-thymine-guanine (CTG) repeat size (<strong>anticipation</strong>), most patients present in late adolescence or early adulthood.<br><br>Affected individuals present with <strong>myotonia</strong> (delayed muscle relaxation after contraction) and <strong>progressive muscle weakness and atrophy</strong>, most prominent on face and distal extremities (e.g., ptosis, temporal wasting and limb muscle atrophy). Oropharyngeal weakness (e.g., dysarthria and dysphagia) may also occur. Other system involvement includes cardiac conduction abnormalities and arrhythmias, testicular atrophy, cataracts and insulin resistance. The testicles of patients with MD are characterized by an increase in the number and size of Leydig cells as well as tubular atrophy, hyalinization, fibrosis of the seminiferous tubules and reduced spermatogenesis.<br><br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/FKtegP_ARPGVGCECWXLhJ8ZIQ86P_Cof/_.png\"></div><br>Genetic testing confirms the diagnosis, and treatment is supportive. Life expectancy is reduced (age 40-50) due to <strong>cardiac</strong> and<strong>&#160;respiratory failure</strong>. &#160;<br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ Autoantibodies against the acetylcholine receptors:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Myasthenia gravis is caused by antibodies against the acetylcholine receptors on the postsynaptic membrane. Affected individuals most commonly present with fluctuating weakness and fatigability of ocular muscles. However, the weakness is fluctuating and more prominent in proximal muscles, and myotonia is not usually seen.</span></div><div style='margin-bottom: 12px;'><strong>❌ Lymphocytic inflammation of the skeletal muscle cells:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Inflammatory myopathies (e.g. polymyositis) results from lymphocytic inflammation of the skeletal muscle cells. Affected patients, however, present with prominent proximal muscles (unlike the distal weakness in this patient), and myotonia would be atypical.</span></div><div style='margin-bottom: 12px;'><strong>✅ Cytosine-thymine-guanine trinucleotide repeat expansion:</strong><br><span style='opacity:0.9'><strong>Correct:&#160;</strong>See Main Explanation.</span></div><div style='margin-bottom: 12px;'><strong>❌ Imprinting of UBE3A on maternal copy of chromosome 15:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Imprinting of UBE3A on maternal copy of chromosome 15 results in Angelman syndrome. Affected patients present with seizures, ataxia, severe intellectual disability, and inappropriate laughter. None of these features are present in this patient.</span></div><div style='margin-bottom: 12px;'><strong>❌ Frameshift deletion mutation in the dystrophin gene:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Duchenne muscular dystrophy typically results from frameshift deletion mutations in the dystrophin gene leading to a truncated or absent dystrophin protein. Affected patients present with proximal muscle weakness and Gower sign (using hand support to push oneself to an upright position). Distal muscles may be involved later in life, and myotonia is not seen.</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    },
    {
      "text": "A 3-year-old boy is brought to the office by his parents because of difficulty keeping up with other children at daycare. The parents report that he has difficulty climbing stairs and seems more tired and less interested in active play. The patient has a history of upper respiratory tract infections twice in the last year. Temperature is 37&#176;C (98.6&#176;F), pulse is 70/min, respirations are 19/min and blood pressure is 100/60 mmHg. Physical examination shows enlarged and nontender calves bilaterally. The rest of the examination is unremarkable. A genetic condition is suspected. The patient&#8217;s family pedigree with respect to this condition is shown with the red arrow indicating his position within the family.<br><br><div><img src=\"https://d16qt3wv6xm098.cloudfront.net/ORjh3S8lTGqLakdGZ5kAYiSzTWezLL5T/_.png\"></div><br><br>Assuming that the genetic condition demonstrates complete penetrance, which of the following inheritance patterns is most likely in this patient? &#160; ",
      "choices": [
        {
          "id": 1,
          "text": "X-linked dominant"
        },
        {
          "id": 2,
          "text": "X-linked recessive"
        },
        {
          "id": 3,
          "text": "Autosomal dominant"
        },
        {
          "id": 4,
          "text": "Autosomal recessive"
        },
        {
          "id": 5,
          "text": "Mitochondrial"
        }
      ],
      "correct_choice_id": 2,
      "solution": "The pedigree shows that only <strong>males&#160;</strong>are affected by the disease. Specifically, male offspring of unaffected parents are affected and there is no evidence of male-to-male transmission. This pattern is most likely suggestive of <strong>X-linked recessive inheritance&#160;</strong>from an <strong>asymptomatic carrier female</strong> in the first generation. In X-linked recessive disease:<br><br><ul><li>&#160;If the<strong>&#160;female is a carrier</strong>, &#160;<strong>50%&#160;</strong>of her <strong>sons</strong> will end up having the mutation and <strong>50%</strong> of <strong>daughters</strong> will be <strong>carriers</strong> for the mutation.&#160;</li><li>&#160;<strong>Affected males&#160;</strong>will always produce <strong>unaffected sons</strong> and <strong>carrier daughters</strong>.&#160;</li></ul>This patient is most likely suffering from <strong>Duchenne muscular dystrophy&#160;</strong>(DMD). About 2/3rds of the time, the affected patient&#8217;s mother is a carrier, and the other 1/3rd of the time the disease is sporadic, which means it is caused by a new mutation. Patients with DMD may experience a gradual and relentless deterioration, and most patients lose ambulation before the age of 12 years. Most patients with DMD die in their 20s or 30s. Therefore, it is important to counsel the parents regarding the risk of having another child with a similar mutation. &#160; <br><br><strong>Becker muscular dystrophy</strong> (BMD) is similar to DMD but manifests later in life. It is also an <strong>X-linked recessive disease</strong>. BMD patients typically have a milder clinical course than those with DMD, and remain ambulatory into adult life. They usually survive beyond the age of 30 years and have a mean age of death in the mid-40s. &#160;<br><br><br><br><hr><h4 style='color: var(--accent-blue); margin-top:16px; margin-bottom:8px;'>Option Analysis</h4><div style='margin-bottom: 12px;'><strong>❌ X-linked dominant:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>In X-linked dominant inheritance, at least one parent (of either sex) is affected.</span></div><div style='margin-bottom: 12px;'><strong>✅ X-linked recessive:</strong><br><span style='opacity:0.9'><strong>Correct:&#160;</strong>See Main Explanation.</span></div><div style='margin-bottom: 12px;'><strong>❌ Autosomal dominant:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>In autosomal dominant inheritance, more than one generation is affected; therefore, at least one parent should also be affected. Both male and females can have the disease.</span></div><div style='margin-bottom: 12px;'><strong>❌ Autosomal recessive:</strong><br><span style='opacity:0.9'><strong>Incorrect:&#160;</strong>Autosomal recessive conditions usually affect only one generation, and both parents of the affected child should at least be a carrier of the disease. With two carrier parents, only 25% of the children will be affected, and both males and females can be affected by the mutation.</span></div><div style='margin-bottom: 12px;'><strong>❌ Mitochondrial:</strong><br><span style='opacity:0.9'><strong>Incorrect:</strong> Diseases that have mitochondrial inheritance are transmitted only by females, and all of the affected female&#8217;s offspring are likely to show the signs of the disease.</span></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "N/A",
      "difficulty": "N/A"
    }
  ]
}